a presentation on GABA including its synthesis, storage and degradation, types of receptors, and implications in various neuropsychiatric disorder, and finally a small chart on the drugs acting on GABA system.
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
-Dr. Ashish Arya Moderator: Dr. M. S. Reddy GABA
Introduction Discovery Synthesis, storage and degradation
Receptors Neuropsychiatric implications Drugs
Introduction Gamma Amino Butyric Acid (GABA) is the major
inhibitory neurotransmitter of the mammalian CNS. It is broadly
distributed in the brain. Implicated in broad range of
neuropsychiatric disorders like seizures, anxiety disorders,
schizophrenia, alcohol dependence etc.
Discovery In 19th century was know as a metabolite of plant and
microorganisms In early 20th century - was isolated as an amino
acid in the brain of mouse through paper chromatography. In 1950
Robert and Frankel discovered GABA in human brain. GABA patches:
inhibitory effects
Synthesis and Storage Synthesised from amino acid L- Glutamic
acid Glutamic acid Decarboxylase (GAD) present in neurons and
peripherally in pancreatic islet cells and body fluids. It
catalysis the removal of - carboxyl group. GAD 65 and GAD 67 genes
encoding GAD
Termination of action GABA transporter (GAT) GAT 1 is
identified as a presynaptic receptor. While GAT 2-4 receptor
location have yet to be identified. Tiagabine blocks GAT1 receptor
increase in synaptic GABA concentration anticonvulsant action.
Termination of action
GABA is catabolised by GABA transaminase (GABA-T). GABA-T is a
cell surface, membrane bound enzyme expressed by neurons and glia,
oriented towards extracellular compartment. Inhibited by valproic
acid and vigabatrin.
Receptors Three major types I. GABA A II. GABA B III. GABA
C
GABA A Ligand gated ion channel. Distributed throughout the
brain. It is a heteropentamer, made of five subunits with each
subunit containing four helical membrane spanning. Ligand binds at
the interface between and domain.
There are many different types of GABA A receptors depending on
the type of subunit present. Subunits also called isoforms
alpha(1-6), beta(1-3), gamma(1-3), delta, epsilon, pi, theta and
rho. Different types of GABA A receptors are present in different
regions of the brain and at different levels of development.
GABA A receptor when activated, mediates an increase in the
conductance. Increase in the influx of Cl- ions causing membrane
hyperpolarization. Increase in the threshold for generating action
potential. Inhibitory action
Allosteric modulation The site where modulators bind is
different from the site of binding of GABA agonist known as
allosteric site and the modulator is called allosteric modulator.
The modulator has no activity of its own. Positive Allosteric
Modulation: ligand binds allosteric site and enhance the action of
neurotransmitter. E.g.BZD Negative Allosteric Modulation: ligand
binds to the allosteric site while an agonist is also bound and the
channel opens less frequently then when
GABA A receptors with alpha 4/6 and delta subunit are
insensitive to benzodiazepines. Binds to modulators naturally
occurring neurosteroids, alcohol and some general anesthetics.
Located extrasynaptically. Regulated by extracelullar GABA molecule
that has escaped reuptake and enzymatic destruction Mediate tonic
inhibition of postsynaptic neuron Not sensitive to BZD no
anxiolytic actions of BZD
GABA A receptor with alpha 1/2/3, beta, gamma 2/3. Postsynaptic
in location phasic inhibition. Bursts of inhibition triggered by
peak concentration of synaptically released GABA. Sensitive to BZD
Anxiolytic actions. Alpha 1 most important for regulating sleep
target for various sedative hypnotic agents. Alpha 2/3 most
important for regulating anxiety. Abnormal expression of alpha 2,
gamma 2 or delta
GABA B Differentiated from GABA A by Insensitive to GABA A
antagonist Bicuculline. Activated by Baclofen Member of G-protein
couples receptor. Dimer of two seven transmembrane spanning
subunits. Widely distributed throughout the CNS.
Located both pre- and post-synaptically. Presynaptically- auto-
and hetero-receptor. Inhibits neurotransmitter release.
Postsynaptically inhibitory long lasting hyperpolarization by
activating K+ channel. GABA B 1 genes GABA B (1A) granule cell
layer GABA B (1B) Purkinje cells. GABA B 2 genes
All GABA B agonist and antagonist bind to the extracellular
domain of GABA B (1) subunit. GABA B receptor antagonist blocks the
action of Gamma Hydroxybutyrate (GHB). GABA C Ligand gated ion
channel. Part of the inhibitory Cl- channel. Physiological role is
not yet discovered.
Anatomy of the GABA system
Corticolimbic region: Localised in the intrinsic/local circuit
neurons Comprise minority of cortical neurons but exhibit profound
degree of inhibition on the activity of glutamatergic pyramidal
cells. In the cortex, GABAergic interneurons are the primary site
of colocalizaton of neuropeptides.
Striatum: GABAergic directly project to the substantia nigra
pars reticulata Striatal GABergic neurons also project to the
globus pallidus to synapse on the pallidal-subthalamic GABAergic
neurons that regulate the excitatory output from the subthalamic
nucleus. Cerebellum: In cerebellum, GABAergic Purkinje cells are
its main efferent system
Neuropsychiatric implications I. Anxiety disorders Including
phobic anxiety disorder, GAD, PTSD, Panic disorder where core
feature is some form anxiety or fear coupled with some form of
worry. Amygdala central circuit amygdala plays central role in the
expression of fear and anxiety. Cortico-Striatal-Thalamo-Cortical
(CSTC) loop linked to worry and obsessions across the spectrum of
anxiety disorders.
Anxiety can also be triggered by memories stored in the
Hippocampus, which activates the Amygdala, in turn causing other
brain regions to activated and generate fear. Particular feature of
PTSD
GABA is the principal inhibitory neurotransmitter in the brain
and serves an important regulatory role in in reducing the activity
of many neurons including those in Amygdala and CSTC loop.
GABAergic dysfunction has been associated with anxiety disorders,
esp with panic disorder. Magnetic Resonant Spectroscopy reveals
significant reduction in GABA levels in the ACC and Basal
ganglia.
PET scanning reveals highly selective reduction in BZD receptor
sites bilaterally in the insular cortex in Panic disorder.
Genomwide screen has shown significant linkage at 15q in a region
containing GABA a receptor subunit genes and panic disorder.
II. Mood disorders Magnetic Resonant Spectroscopy reveals
significant reduction in both GABA and Glutamate in Prefrontal
cortex in Major Depressive Disorder. Post mortem studies revealed
up regulation of the GABA receptors alpha1 and 2 subunits,
consistent with a reduction in GABAergic neurotransmission. Reduced
levels of GABA in occipital cortex in episodes of major depressive
disorder
In animal studies valproate, carbamazapine, lithium and
lamotrigine a/w in increase in GABA turnover in brain. Endocrinal
hypothesis: estrogen induces downregulation of GAD resulting in
inhibitory action on GABA formation resulting in increased activity
of pyramidal cells.
III. Schizophrenia Corticobrainstem glutamate pathways and NMDA
receptor function hypothesis Descending glutaminergic pathway
projects from cortical pyramidal cells to brainstem
neurotransmitter centres inclusing raphe for serotonin, VTA and
substantia nigra for dopamine and locus ceruleus for
norepinephrine.
The descending corticobrainstem glutamate pathway acts as a
brake to the mesolimbic dopamine pathway through an inhibitory GABA
interneuron in the VTA. Which are activated by NMDA receptors.
Corticostriatal glutamate pathway (CSTC loop) Descending
glutaminergic output from the pyramidal cells in cortex nucleus
accumbens in ventral striatum forming first leg of the CSTC loop.
Ascending pathway from thalamus to cortex return leg of the CSTC
loop. GABA neurons located in the thalamus acts as the sensory
filters and prevents too much sensory input from penetrating the
thalamus into the cortex.
Dopamine inhibits GABA in CSTC loop reduces the effectiveness
of thalamic filter opposes the excitatory input of the glutamate
from corticostriatal glutamate projections.
Mesolimbic dopamine hyperactivity reduces thalamic inhibition
increases cortical activation NMDA receptor hypofunction in
corticostriatal and corticoaccumbens projections sensory
overload.
Postmortem studies indicated a reduction in the activity of GAD
in the cortex in patients with schizophrenia. Neurochemistry:
reduced expression of GAD 67, Parvalbumin-positive GABAergic
interneurons and the GABA transporter (GAT). Upregulation of GABA
receptors supports hypofunction of presynaptic GABAergic
neurons.
Epilepsy In epilepsy, abnormal electrical discharges are due to
hyperexcitable neurons with sustained postsynaptic depolarization.
Decreased GABA inhibition of cortical excitability is one of the
proposed mechanism. Penicllin induced cortical injury causes
seizures through decreased GABA inhibition. BZD and barbiturates
reduces seizures by enhancing GABA receptor current and valproate
through blockade of GABA catabolism.
Reward circuits Mesolimbic dopamine pathway is the final common
pathway of reinforcement and reward in the brain. Reactive reward
system: bottom up provides motivational and behavioural drive in
ascending mesolimbic pathway. Reflective reward system: top down
connections from prefrontal cortex down to nucleus accumbens and
involved in regulating impulses and keeping some flexibility of
choice.
Turning reward into goal directed behaviour The output of the
reward system is the completion of CSTC loop. The
striatal/accumbens component of reward circuitry has output
GABAergic neurons that travel to another part of striatal complex
the ventral pallidum. From there the connections go to thalamus and
back to prefrontal cortex where behaviours are implemented such as
learning and activities in long term rewards and drug seeking
behaviour
Alcohol and reward Alcohol reinforcing effects are mediated by
its effects specially on mesolimbic reward circuitry. Acts at
presynaptic glutamate receptors and voltage sensitive Calcium
channels to inhibit glutamate release. Enhance the GABA release by
blocking the presynaptic GABA B receptors and acts on postsynaptic
GABA A receptors of delta subtypes
Opiate neurons arise from arcuate nucleus and projects to the
glutamate and GABA neurons. Alcohol acts on mu opiate receptors
which increases the dopamine release in the nucleus accumbens.
Persistent abuse and dependency on ethanol result in downregulation
of GABA and an upregulation of NMDA receptors such that sudden
discontinuation results in hyperexcitable state characterised by
delirium tremens.
Nicotine and reward:
Varenicline: nicotine partial agonist
Sleep and Wakefulness CSTC loop regulate the arousal and part
by controlling the size of thalamic filter. Sleep wake switch: set
of circuit present in hypothalamus that regulate sleep/wake
discontinuously like an on/off switch. Tuberomammillary nucleus
wake promoter Vantrolateral preoptic nucleus(VLPO) sleep
promoter.
Orexin containing neurons of lateral hypothalamus- promotes
wakefullness. Melatonin sensitive neurons of the Suprachiasmatic
nucleus (SCN) regulates circadian input to the sleep/wake
switch.
Insomnia occurs when it fails to filter out sensory input to
the cortex in night and daytime sleepiness when it filters out too
much sensory input to the cortex in the daytime.